Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Enterprise Value: 2011-2025

Historic Enterprise Value for Adma Biologics (ADMA) over the last 12 years, with Sep 2025 value amounting to $3.4 billion.

  • Adma Biologics' Enterprise Value fell 24.84% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year decrease of 27.71%. This contributed to the annual value of $4.0 billion for FY2024, which is 307.30% up from last year.
  • Latest data reveals that Adma Biologics reported Enterprise Value of $3.4 billion as of Q3 2025, which was down 19.27% from $4.3 billion recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Enterprise Value peaked at $4.6 billion during Q1 2025, and registered a low of $115.6 million during Q3 2021.
  • Moreover, its 3-year median value for Enterprise Value was $2.5 billion (2024), whereas its average is $2.5 billion.
  • Per our database at Business Quant, Adma Biologics' Enterprise Value slumped by 35.69% in 2021 and then soared by 525.56% in 2024.
  • Over the past 5 years, Adma Biologics' Enterprise Value (Quarterly) stood at $225.0 million in 2021, then skyrocketed by 200.87% to $677.0 million in 2022, then soared by 43.29% to $970.0 million in 2023, then skyrocketed by 307.30% to $4.0 billion in 2024, then dropped by 24.84% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q3 2025, $4.3 billion for Q2 2025, and $4.6 billion during Q1 2025.